The 20 Best WT1-Related Wilms Tumor Syndromes Doctors Near Me in Pittsburgh, PA

Tatum V. Tarin, MD, is an Associate Professor of Urology at the University of Pittsburgh School of Medicine. He earned his medical degree from the University of Pittsburgh, and completed residencies in surgery and urology at Stanford University Medical Center. He also completed a fellowship in urological oncology at Memorial Sloan-Kettering Cancer Center in New York, N.Y., where he was a clinical instructor for two years prior to joining UPMC. Dr. Tarin is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Lymphadenectomy, and Nephrectomy. Dr. Tarin is board certified in American Board Of Urology. Dr. Tarin is currently accepting new patients.

Bishoy A. Gayed, MD, is an assistant professor of urology at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Missouri Kansas City. Dr. Gayed completed his residency in urology at UPMC and a fellowship in urologic oncology at the University of Texas Southwestern Medical Center. He specializes in urology, urologic oncology, urologic surgery, and the management of tumors of the kidney, bladder, prostate, ureteral, testicular, penile, and adrenal cancers. Dr. Gayed is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Hydronephrosis, Nephrectomy, and Ureteroscopy. Dr. Gayed is board certified in American Board Of Urology. Dr. Gayed is currently accepting new patients.

Ronald L. Hrebinko, MD, is a professor of urology at the University of Pittsburgh School of Medicine. He specializes in all genitourinary cancers with special expertise in continent urinary diversion, nephron-sparing surgery for renal cancer, laparoscopic kidney surgery, nerve-sparing surgery for the prostate, and testis cancer.Dr. Hrebinko is board-certified in urology. He received an undergraduate degree with honors from Dartmouth College in N.H., and a medical degree at the University of Pittsburgh School of Medicine. Dr. Hrebinko completed a residency at UPMC in the Department of Surgery, and a fellowship at Roswell Park Cancer Institute, in Buffalo, N.Y.Dr. Hrebinko is a member of professional organizations, such as the American Urologic Association, Society of Urologic Oncology, and the American Society of Clinical Oncology.Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule. Dr. Hrebinko is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hrebinko is board certified in American Board Of Urology. Dr. Hrebinko is currently accepting new patients.

Roby A. Thomas, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Thomas is trained in the management of all cancers and blood disorders with a focus in genitourinary and gastrointestinal malignancies. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy. Dr. Thomas is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Thomas is currently accepting new patients.

Dr. Maranchie is a surgical oncologist specializing in urologic cancers of the urinary tract and male genitalia.  She completed urology residency at Harvard University in 1999, followed by a fellowship in Urologic Oncology at the National Cancer Institute.  Her practice is focused on the care of patients with cancer of the kidney, bladder and testis, employing minimally invasive approaches, nephron-sparing and nerve-sparing surgery and urinary tract reconstruction.  She has specialty expertise in familial or inherited cancer syndromes, offering targeted surveillance with organ-preserving surgery when indicated.LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling. Dr. Maranchie is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy. Dr. Maranchie is board certified in American Board Of Urology. Dr. Maranchie is currently accepting new patients.

Shifeng Mao is a Hematologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Mao is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes.

Goutham Vemana is a Urologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Vemana is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Clear Cell Sarcoma, Ureteroscopy, and Nephrectomy.

Stephen Jackman, MD, is a urologic surgeon focused on minimally invasive surgery for kidney and prostate cancer as well as kidney stones. His areas of specialty include surgical techniques involving advanced laparoscopy, robotics, and complex kidney stone disease. Dr. Jackman is Professor and Vice Chair of Urology at the University of Pittsburgh School of Medicine. Dr. Jackman is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Boils, Folliculitis, Ureteroscopy, and Endoscopy. Dr. Jackman is board certified in American Board Of Urology. Dr. Jackman is currently accepting new patients.

Shannon L. Puhalla, MD, is assistant professor of medicine at the University of Pittsburgh School of Medicine, and a medical oncologist and hematologist at UPMC Hillman Cancer Center. She specializes in breast oncology, Phase I clinical trials, and novel therapeutics in breast cancer. Dr. Puhalla is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Puhalla is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Puhalla is currently accepting new patients.

Vikram C. Gorantla, MD, specializes in the treatment of sarcoma, breast cancer, gastrointestinal malignancies, and head and neck cancers. Board-certified in internal medicine and medical oncology, he received his medical degree at the University of Texas Southwestern Medical School in Dallas. He completed his internal medicine residency at Washington University, St. Louis, MO, and his hematology/oncology fellowship at UPMC.Dr. Gorantla has a dedicated day seeing breast cancer patients at the Magee-Womens Cancer Progam. He also collaborates with surgical oncologists and gynecologists/oncologists to provide multidisciplinary care to patients. Dr. Gorantla is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Endoscopy, and Gamma Knife Radiosurgery. Dr. Gorantla is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Gorantla is currently accepting new patients.

David Friedland is a Hematologist and an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Friedland is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Gregory Halenda, MD, is certified in urology by the American Board of Urology. He is affiliated with UPMC Magee-Womens Hospital.  Dr. Halenda received his medical degree from Thomas Jefferson University Medical College and completed his residency at Penn State University College of Medicine. Dr. Halenda is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Kidney Stones, Perirenal Abscess, Prostatectomy, and Ureteroscopy. Dr. Halenda is board certified in American Board Of Urology. Dr. Halenda is currently accepting new patients.

Ronald Brennan, MD, specializes in diagnostic radiology and is certified in diagnostic radiology by the American Board of Radiology. He practices at University of Pittsburgh Physicians, Department of Radiology and is affiliated with UPMC Horizon, and UPMC Jameson. He completed his medical degree at Hahnemann University Hospital and residency at Mount Sinai Medical Center. Dr. Brennan is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Ascites, Cerebellar Multiple System Atrophy, Hepatocerebral Degeneration, and Cerebellar Degeneration. Dr. Brennan is board certified in American Board Of Radiology.

Dr. Michael C. Ost is a urologist who treats a wide array of urologic conditions in both adults and children. He is skilled in minimally invasive surgery, utilizing robotics, laparoscopy, and endourologic techniques. His areas of expertise include the treatment of kidney cancer, congenital renal anomalies, ureteral injuries and abnormalities, and complex stone disease.Dr. Ost received his medical degree from the Mount Sinai School of Medicine in New York City. He received subspecialty fellowship training in both endourology (Northwell Health System – New York) and pediatric urology (UPMC Children’s Hospital of Pittsburgh). He was the first urologist in the United States to receive such training to treat a wide spectrum of urologic diseases in a minimally invasive fashion in both adults and children. He is widely published and has lectured nationally and internationally on his areas of specialization. Dr. Ost also received his MBA from the Ross School of Business at the University of Michigan.In addition to his clinical practice as a professor of urology, Dr. Ost serves as Director of Pediatric Surgical Outreach at UPMC Children’s Hospital of Pittsburgh and Assistant Dean for Interprofessional Education and Technology at the University of Pittsburgh School of Medicine. Dr. Ost is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Anorchia, Ureterocele, Horseshoe Kidney, Lithotripsy, and Ureteroscopy. Dr. Ost is board certified in American Board Of Urology and American Board Of Urology. Dr. Ost is currently accepting new patients.

Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, and Clear Cell Sarcoma.

Benjamin J. Davies, MD, is a professor of urology at the University of Pittsburgh. He specializes in robotic prostatectomy, robotic cystectomy, and kidney and testicular cancer.Dr. Davies is board-certified in urology. He completed an undergraduate degree at Columbia University in New York and a medical degree at Mount Sinai Medical School in New York. Dr. Davies completed a residency at UPMC, and a fellowship of urologic oncology at University of California, San Francisco.Dr. Davies is a member of professional organizations, such as the American Urologic Association, American Medical Association and the Pittsburgh Urologic Society. He also maintains research interests in prostate cancer epidemiology and surgical outcomes. Dr. Davies is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Cervical Myelopathy, Bladder Cancer, Prostate Cancer, Vasectomy, and Cystectomy. Dr. Davies is board certified in American Board Of Urology. Dr. Davies is currently accepting new patients.

Daniel P. Petro, MD, is a medical oncologist and hematologist at Hillman Cancer Center. He treats all cancer types, and has a special interest in a multidisciplinary approach to thoracic malignancies. Dr. Petro is also heavily involved in the research of Phase I trials. Dr. Petro is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Petro is board certified in American Board Of Internal Medicine. Dr. Petro is currently accepting new patients.

Quoc-Dien Trinh, MD, MBA, serves as the Chair of the Department of Urology, University of Pittsburgh School of Medicine, and Chair of Urology, UPMC. A globally recognized urological surgeon-scientist, Dr. Trinh has been honored with the 2021 Outstanding Citizenship Award from Brigham and Women’s Hospital and the 2022 American Urological Association Young Urologist of the Year award for New England. He is recognized as a Castle Connolly Top Doctor and a Top Asian American Pacific Islander Doctor. Dr. Trinh is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy. Dr. Trinh is board certified in American Board Of Urology. Dr. Trinh is currently accepting new patients.

Joel D. Bigley, MD, is an assistant professor of urology at the University of Pittsburgh School of Medicine. He received his medical degree from the West Virginia School of Medicine in Morgantown, W. Va., and also completed residencies in general surgery and urology at the University of Pittsburgh. Dr. Bigley is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Boils, Folliculitis, Ureteroscopy, and Lithotripsy. Dr. Bigley is board certified in American Board Of Urology. Dr. Bigley is currently accepting new patients.

Anwaar Saeed, MD, is an Associate Professor of Medicine and the Chief of the Gastrointestinal (GI) Medical Oncology Program at the University of Pittsburgh, University of Pittsburgh Medical Center (UPMC), and UPMC Hillman Cancer Center. She also serves as the Vice Chair of the Colorectal Cancer Committee of the NSABP Foundation. Her research efforts are focused on immune modulatory approaches in patients with gastric & esophageal cancer, colon cancer and hepatocellular carcinoma as well as chemoprevention/ immunoprevention in the high-risk GI population. She has published more than 150 peer reviewed papers, posters and book chapters, and have led more than 40 clinical trials, focused on various immune modulatory regimens including but not limited to immune checkpoint inhibitor combinations with chemotherapy, other checkpoint inhibitors, antibody drug conjugates, bi-specific T cell engagers (BiTE), angiogenesis inhibitors, as well as immunotherapy combinations with regional approaches like stereotactic radiosurgery and intensity-modulated radiation therapy. She currently leads several investigator-initiated trials focused on novel targeted immunotherapy combinations including the ongoing phase I/II CAMILLA multicohort study looking at Cabozantinib plus Durvalumab with or without Tremelimumab in GI malignancies. Results from phase I/II part of the CAMILLA led to the development of the currently ongoing global pivotal trial, STELLAR 303, in patients with previously treated microsatellite stable colorectal cancer. She is also the study chair for a soon to open SWOG/intergroup NCI national trial (S2303) testing a novel chemo-immunotherapy regimen in patients with advanced gastric & esophageal adenocarcinoma. Dr. Saeed is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Stomach Cancer, Familial Colorectal Cancer, and Gamma Knife Radiosurgery. Dr. Saeed is board certified in American Board Of Internal Medicine. Dr. Saeed is currently accepting new patients.